• Chief Healthcare ExecutiveChief Healthcare Executive
  • Formulary WatchFormulary Watch
  • Managed Healthcare Executive
  • Medical EconomicsMedical Economics
Managed Healthcare Executive
Managed Healthcare Executive
Resource Centers
View MoreBiosimilarsBlood CancerCovid-19DermatologyDigital HealthEye CareHemophiliaHIVLiver DiseaseLung CancerMultiple SclerosisNeonatal CarePost-Acute CarePrescription Digital TherapeuticsSleep DisordersUlcerative ColitisVaccines
Spotlight
AMCP AnnualAsembia’s 2022 Specialty Pharmacy SummitAMCP NexusK-CastPBMI National ConferencePopulation Health PerspectivesUpdates in Vaccine Management
Business
View MoreBusiness StrategyChronic DiseaseConsumersDrug CostsDrug PipelineFormularyHealth ManagementHealth/Disease StrategyHospitals & ProvidersIndustry AnalysisPharmacyPolitics and PolicyPractice ManagementReimbursementTechnology
News
Media
Expert Interviews
K-Cast
Medical World News
Podcasts
Population Health Perspectives
ConferencesPartners
Publications
MHE Publication
Supplements And Featured Publications
Events
Virtual Events
CME/CE
Resources
PBM Leaders
Sponsored
Sponsored Content
Surveys
Subscribe
eNewsletter
Print Subscription
  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations

© 2023 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.

Advertisement
Resource CentersSee All >
  • Biosimilars
  • Blood Cancer
  • Covid-19
  • Dermatology
  • Digital Health
  • Eye Care
  • Hemophilia
  • HIV
  • Liver Disease
  • Lung Cancer
  • Multiple Sclerosis
  • Neonatal Care
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Sleep Disorders
  • Ulcerative Colitis
  • Vaccines
Spotlight
  • AMCP Annual
  • Asembia’s 2022 Specialty Pharmacy Summit
  • AMCP Nexus
  • K-Cast
  • PBMI National Conference
  • Population Health Perspectives
  • Updates in Vaccine Management
BusinessSee All >
  • Business Strategy
  • Chronic Disease
  • Consumers
  • Drug Costs
  • Drug Pipeline
  • Formulary
  • Health Management
  • Health/Disease Strategy
  • Hospitals & Providers
  • Industry Analysis
  • Pharmacy
  • Politics and Policy
  • Practice Management
  • Reimbursement
  • Technology
  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Informations
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.

Challenges and Considerations in Treatment of Adult Spinal Muscular Atrophy

Key opinion leader discusses considerations for adult patients with spinal muscular atrophy (SMA) including disease burden, treatment evaluation, and the use of real-world evidence.

EP. 1: Identifying Adult Patients with Spinal Muscular Atrophy

December 21st 2020

EP. 2: Impact of Spinal Muscular Atrophy on Quality of Life

December 21st 2020

EP. 3: Spinal Muscular Atrophy and Healthcare Resource Utilization

December 21st 2020

EP. 4: Importance of Establishing Care Early in SMA Diagnosis

December 21st 2020

EP. 5: Treatment Challenges in Spinal Muscular Atrophy Patients

December 21st 2020

EP. 6: Spinal Muscular Atrophy Treatment Goals and Considerations

December 21st 2020

EP. 7: Quantifying and Measuring Treatment Success in SMA

December 21st 2020

EP. 8: Utilizing Real-World Data to Drive Evidence-Based SMA Treatment

December 21st 2020

Advertisement
Advertisement